Gadola SD - Search Results

1

Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases.

Gadola SD, Silk JD, Jeans A, Illarionov PA, Salio M, Besra GS, Dwek R, Butters TD, Platt FM, Cerundolo V. Gadola SD, et al. J Exp Med. 2006 Oct 2;203(10):2293-303. doi: 10.1084/jem.20060921. Epub 2006 Sep 18. J Exp Med. 2006. PMID: 16982810 Free PMC article.

2

Valpha24-JalphaQ-independent, CD1d-restricted recognition of alpha-galactosylceramide by human CD4(+) and CD8alphabeta(+) T lymphocytes.

Gadola SD, Dulphy N, Salio M, Cerundolo V. Gadola SD, et al. J Immunol. 2002 Jun 1;168(11):5514-20. doi: 10.4049/jimmunol.168.11.5514. J Immunol. 2002. PMID: 12023346

3

Generation of CD1 tetramers as a tool to monitor glycolipid-specific T cells.

Gadola SD, Karadimitris A, Zaccai NR, Salio M, Dulphy N, Shepherd D, Jones EY, Cerundolo V. Gadola SD, et al. Philos Trans R Soc Lond B Biol Sci. 2003 May 29;358(1433):875-7. doi: 10.1098/rstb.2003.1267. Philos Trans R Soc Lond B Biol Sci. 2003. PMID: 12803920 Free PMC article. Review.

4

The crystal structure of human CD1d with and without alpha-galactosylceramide.

Koch M, Stronge VS, Shepherd D, Gadola SD, Mathew B, Ritter G, Fersht AR, Besra GS, Schmidt RR, Jones EY, Cerundolo V. Koch M, et al. Among authors: gadola sd. Nat Immunol. 2005 Aug;6(8):819-26. doi: 10.1038/ni1225. Epub 2005 Jul 10. Nat Immunol. 2005. PMID: 16007090

5

Structure and binding kinetics of three different human CD1d-alpha-galactosylceramide-specific T cell receptors.

Gadola SD, Koch M, Marles-Wright J, Lissin NM, Shepherd D, Matulis G, Harlos K, Villiger PM, Stuart DI, Jakobsen BK, Cerundolo V, Jones EY. Gadola SD, et al. J Exp Med. 2006 Mar 20;203(3):699-710. doi: 10.1084/jem.20052369. Epub 2006 Mar 6. J Exp Med. 2006. PMID: 16520393 Free PMC article.

6

Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals.

Brennan PJ, Tatituri RV, Brigl M, Kim EY, Tuli A, Sanderson JP, Gadola SD, Hsu FF, Besra GS, Brenner MB. Brennan PJ, et al. Among authors: gadola sd. Nat Immunol. 2011 Oct 30;12(12):1202-11. doi: 10.1038/ni.2143. Nat Immunol. 2011. PMID: 22037601 Free PMC article.

7

The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients.

Markel G, Mussaffi H, Ling KL, Salio M, Gadola S, Steuer G, Blau H, Achdout H, de Miguel M, Gonen-Gross T, Hanna J, Arnon TI, Qimron U, Volovitz I, Eisenbach L, Blumberg RS, Porgador A, Cerundolo V, Mandelboim O. Markel G, et al. Blood. 2004 Mar 1;103(5):1770-8. doi: 10.1182/blood-2003-06-2114. Epub 2003 Nov 6. Blood. 2004. PMID: 14604968 Free article.

8

Frequency and phenotype of circulating Valpha24/Vbeta11 double-positive natural killer T cells during hepatitis C virus infection.

Lucas M, Gadola S, Meier U, Young NT, Harcourt G, Karadimitris A, Coumi N, Brown D, Dusheiko G, Cerundolo V, Klenerman P. Lucas M, et al. J Virol. 2003 Feb;77(3):2251-7. doi: 10.1128/jvi.77.3.2251-2257.2003. J Virol. 2003. PMID: 12525661 Free PMC article.

9

Structure of human CD1b with bound ligands at 2.3 A, a maze for alkyl chains.

Gadola SD, Zaccai NR, Harlos K, Shepherd D, Castro-Palomino JC, Ritter G, Schmidt RR, Jones EY, Cerundolo V. Gadola SD, et al. Nat Immunol. 2002 Aug;3(8):721-6. doi: 10.1038/ni821. Epub 2002 Jul 15. Nat Immunol. 2002. PMID: 12118248

10

The crystal structure of human CD1b with a bound bacterial glycolipid.

Batuwangala T, Shepherd D, Gadola SD, Gibson KJ, Zaccai NR, Fersht AR, Besra GS, Cerundolo V, Jones EY. Batuwangala T, et al. Among authors: gadola sd. J Immunol. 2004 Feb 15;172(4):2382-8. doi: 10.4049/jimmunol.172.4.2382. J Immunol. 2004. PMID: 14764708

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page